Phase 2 Readout~quarter
Phase 2 Readout: lb-102
- Drug
- lb-102
- Indication
- Bipolar Depression
Other upcoming events for LBRX
Phase 3 ReadoutPhase 3 Topline: A Randomized, Double-blinded, Placebo-controlled, Multicenter Study to Evaluate the Antipsychotic Ef
Phase 2 ReadoutPhase 2 Readout: lb-102
Phase 3 ReadoutPhase 3 Topline: A 52 Week, Open Label Safety and Tolerability Study of LB-102 in Adult Patients With Schizophrenia
Phase 2 ReadoutPhase 2 Readout: lb-102
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.